应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
MBRX Moleculin Biotech, Inc.
未开盘 04-25 16:00:00 EDT
4.31
-0.04
-0.96%
盘后
4.45
+0.14
+3.29%
16:00 EDT
最高
4.50
最低
4.28
成交量
2.26万
今开
4.30
昨收
4.35
日振幅
5.06%
总市值
959.66万
流通市值
829.46万
总股本
222.75万
成交额
9.87万
换手率
1.17%
流通股本
192.53万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Moleculin Biotech, Inc.盘中异动 临近收盘股价大涨5.35%报4.53美元
自选股智能写手 · 04-24 03:41
Moleculin Biotech, Inc.盘中异动 临近收盘股价大涨5.35%报4.53美元
Moleculin Biotech, Inc.盘中异动 临近收盘股价大跌6.45%
自选股智能写手 · 04-23
Moleculin Biotech, Inc.盘中异动 临近收盘股价大跌6.45%
Moleculin Biotech, Inc.盘中异动 早盘股价大涨9.81%
自选股智能写手 · 04-18
Moleculin Biotech, Inc.盘中异动 早盘股价大涨9.81%
Moleculin Biotech, Inc.盘中异动 下午盘股价大跌5.12%
自选股智能写手 · 04-12
Moleculin Biotech, Inc.盘中异动 下午盘股价大跌5.12%
Moleculin Biotech, Inc.盘中异动 股价大跌6.57%报5.09美元
自选股智能写手 · 04-04
Moleculin Biotech, Inc.盘中异动 股价大跌6.57%报5.09美元
Moleculin Biotech, Inc.盘中异动 早盘急速上涨6.20%报4.97美元
自选股智能写手 · 03-27
Moleculin Biotech, Inc.盘中异动 早盘急速上涨6.20%报4.97美元
Moleculin Biotech, Inc.盘中异动 快速下挫5.61%报4.96美元
自选股智能写手 · 03-26
Moleculin Biotech, Inc.盘中异动 快速下挫5.61%报4.96美元
Moleculin Biotech, Inc.盘中异动 快速上涨5.18%
自选股智能写手 · 03-25
Moleculin Biotech, Inc.盘中异动 快速上涨5.18%
Moleculin 生物技术公司公布截至 12 月的季度业绩 - 收益摘要
Reuters · 03-23
Moleculin 生物技术公司公布截至 12 月的季度业绩 - 收益摘要
Moleculin Biotech, Inc.盘中异动 大幅拉升6.99%报0.450美元
自选股智能写手 · 03-21
Moleculin Biotech, Inc.盘中异动 大幅拉升6.99%报0.450美元
Moleculin Biotech Inc 预计每股亏损 20 美分 - 财报前瞻
Reuters · 03-19
Moleculin Biotech Inc 预计每股亏损 20 美分 - 财报前瞻
Moleculin Biotech, Inc.盘中异动 早盘急速下跌8.33%报0.491美元
自选股智能写手 · 03-15
Moleculin Biotech, Inc.盘中异动 早盘急速下跌8.33%报0.491美元
Moleculin Biotech, Inc.盘中异动 早盘股价大跌6.65%
自选股智能写手 · 03-12
Moleculin Biotech, Inc.盘中异动 早盘股价大跌6.65%
Moleculin Biotech, Inc.盘中异动 临近收盘股价大跌5.01%
自选股智能写手 · 03-12
Moleculin Biotech, Inc.盘中异动 临近收盘股价大跌5.01%
加载更多
公司概况
公司名称:
Moleculin Biotech, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Moleculin Biotech, Inc.是一家于2015年7月在特拉华州成立的临床药物研制公司,着眼于开发抗癌药物的研发,主要与德克萨斯州大学的M.D. Anderson癌症中心合作。他们的主要研制药品是脂质的安那霉素,用于治疗复发性或急性白血病。除此之外还有两种正在开发的其他药物,一是WP1066药物,主要控制参与癌症的关键转录调控因子;二是WP1122药物,主要通过分子靶来影响癌症细胞的代谢过程。
发行价格:
--
{"stockData":{"symbol":"MBRX","market":"US","secType":"STK","nameCN":"Moleculin Biotech, Inc.","latestPrice":4.3082,"timestamp":1714075200000,"preClose":4.35,"halted":0,"volume":22596,"hourTrading":{"tag":"盘后","latestPrice":4.45,"preClose":4.3082,"latestTime":"16:00 EDT","volume":2,"amount":8.9,"timestamp":1714075201139},"delay":0,"floatShares":1925314,"shares":2227516,"eps":-15.068257,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.0418,"latestTime":"04-25 16:00:00 EDT","open":4.3,"high":4.4999,"low":4.28,"amount":98652.448079,"amplitude":0.050552,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-15.068257,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1714118400000},"adr":0,"adjPreClose":4.35,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":4.43,"preClose":4.35,"latestTime":"09:02 EDT","volume":5,"amount":22.4199985,"timestamp":1714050177829},"postHourTrading":{"tag":"盘后","latestPrice":4.45,"preClose":4.3082,"latestTime":"16:00 EDT","volume":2,"amount":8.9,"timestamp":1714075201139},"volumeRatio":1.230411},"requestUrl":"/m/hq/s/MBRX?invite=TIGER026","defaultTab":"news","newsList":[{"id":"2429141664","title":"Moleculin Biotech, Inc.盘中异动 临近收盘股价大涨5.35%报4.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429141664","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429141664?lang=zh_cn&edition=full","pubTime":"2024-04-24 03:41","pubTimestamp":1713901267,"startTime":"0","endTime":"0","summary":"北京时间2024年04月24日03时41分,Moleculin Biotech, Inc.股票出现波动,股价急速拉升5.35%。截至发稿,该股报4.53美元/股,成交量4952股,换手率0.22%,振幅4.66%。Moleculin Biotech, Inc.股票所在的生物技术行业中,整体涨幅为1.68%。Moleculin Biotech, Inc.公司简介:Moleculin Biotech Inc是一家临床阶段的制药公司,专注于通过开发其候选药物来治疗高度耐药的癌症和病毒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240424034107861e83da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240424034107861e83da&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429905660","title":"Moleculin Biotech, Inc.盘中异动 临近收盘股价大跌6.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429905660","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429905660?lang=zh_cn&edition=full","pubTime":"2024-04-23 03:53","pubTimestamp":1713815607,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日03时53分,Moleculin Biotech, Inc.股票出现波动,股价大幅跳水6.45%。Moleculin Biotech, Inc.股票所在的生物技术行业中,整体涨幅为1.27%。其相关个股中,Moolec Science Sa C/Wts 、Nkgen Biotech Inc C/Wts 31/05/2028、Moolec Science Sa涨幅较大,Moolec Science Sa、Phio Pharmaceuticals Corp.、Nkgen Biotech, Inc.较为活跃,换手率分别为205.86%、147.02%、102.78%,振幅较大的相关个股有Moolec Science Sa C/Wts 、Moolec Science Sa、Phio Pharmaceuticals Corp.,振幅分别为252.97%、82.14%、68.75%。Moleculin Biotech, Inc.公司简介:Moleculin Biotech Inc是一家临床阶段的制药公司,专注于通过开发其候选药物来治疗高度耐药的癌症和病毒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240423035329861e7e75&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240423035329861e7e75&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428591237","title":"Moleculin Biotech, Inc.盘中异动 早盘股价大涨9.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428591237","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428591237?lang=zh_cn&edition=full","pubTime":"2024-04-18 21:31","pubTimestamp":1713447069,"startTime":"0","endTime":"0","summary":"北京时间2024年04月18日21时31分,Moleculin Biotech, Inc.股票出现波动,股价快速上涨9.81%。Moleculin Biotech, Inc.股票所在的生物技术行业中,整体跌幅为0.25%。其相关个股中,Bio-Path Holdings, Inc.、Citius Pharmaceuticals, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 涨幅较大,Bio-Path Holdings, Inc.、Benitec Biopharma Inc.、Soligenix, Inc.较为活跃,换手率分别为1580.27%、43.59%、23.06%,振幅较大的相关个股有Bio-Path Holdings, Inc.、Imunon, Inc.、Abvc Biopharma, Inc.,振幅分别为14.81%、14.04%、11.77%。Moleculin Biotech, Inc.公司简介:Moleculin Biotech Inc是一家临床阶段的制药公司,专注于通过开发其候选药物来治疗高度耐药的癌症和病毒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404182131097a53c963&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404182131097a53c963&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426295377","title":"Moleculin Biotech, Inc.盘中异动 下午盘股价大跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426295377","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426295377?lang=zh_cn&edition=full","pubTime":"2024-04-12 01:46","pubTimestamp":1712857609,"startTime":"0","endTime":"0","summary":"北京时间2024年04月12日01时46分,Moleculin Biotech, Inc.股票出现异动,股价大幅下跌5.12%。Moleculin Biotech, Inc.股票所在的生物技术行业中,整体跌幅为0.27%。其相关个股中,Rallybio Corporation、Eliem Therapeutics, Inc、Candel Therapeutics, Inc.涨幅较大,Adial Pharmaceuticals, Inc、Aptevo Therapeutics Inc.、Scisparc Ltd.较为活跃,换手率分别为783.62%、584.71%、513.30%,振幅较大的相关个股有Veru Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Rallybio Corporation,振幅分别为53.23%、52.42%、50.92%。Moleculin Biotech, Inc.公司简介:Moleculin Biotech Inc是一家临床阶段的制药公司,专注于通过开发其候选药物来治疗高度耐药的癌症和病毒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412014650861e5079&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412014650861e5079&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424247998","title":"Moleculin Biotech, Inc.盘中异动 股价大跌6.57%报5.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2424247998","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424247998?lang=zh_cn&edition=full","pubTime":"2024-04-04 01:07","pubTimestamp":1712164033,"startTime":"0","endTime":"0","summary":"北京时间2024年04月04日01时07分,Moleculin Biotech, Inc.股票出现异动,股价快速下挫6.57%。截至发稿,该股报5.09美元/股,成交量2.4632万股,换手率1.11%,振幅7.89%。Moleculin Biotech, Inc.股票所在的生物技术行业中,整体涨幅为0.24%。Moleculin Biotech, Inc.公司简介:Moleculin Biotech Inc是一家临床阶段的制药公司,专注于通过开发其候选药物来治疗高度耐药的癌症和病毒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040401071487e7dfbf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040401071487e7dfbf&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422997748","title":"Moleculin Biotech, Inc.盘中异动 早盘急速上涨6.20%报4.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422997748","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422997748?lang=zh_cn&edition=full","pubTime":"2024-03-27 21:36","pubTimestamp":1711546568,"startTime":"0","endTime":"0","summary":"北京时间2024年03月27日21时36分,Moleculin Biotech, Inc.股票出现异动,股价急速上涨6.20%。Moleculin Biotech, Inc.股票所在的生物技术行业中,整体跌幅为0.07%。其相关个股中,Ibio, Inc.、Lixte Biotechnology Holdings, Inc.、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 涨幅较大,Ibio, Inc.、Lixte Biotechnology Holdings, Inc.、Hoth Therapeutics, Inc.较为活跃,换手率分别为1033.24%、512.02%、50.48%,振幅较大的相关个股有Ibio, Inc.、Apollomics Inc C/Wts 01/04/2028 、Lixte Biotechnology Holdings, Inc.,振幅分别为53.04%、27.59%、27.27%。Moleculin Biotech, Inc.公司简介:Moleculin Biotech Inc是一家临床阶段的制药公司,专注于通过开发其候选药物来治疗高度耐药的癌症和病毒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240327213609861e1ada&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240327213609861e1ada&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422192613","title":"Moleculin Biotech, Inc.盘中异动 快速下挫5.61%报4.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422192613","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422192613?lang=zh_cn&edition=full","pubTime":"2024-03-26 21:34","pubTimestamp":1711460049,"startTime":"0","endTime":"0","summary":"北京时间2024年03月26日21时34分,Moleculin Biotech, Inc.股票出现波动,股价大幅跳水5.61%。截至发稿,该股报4.96美元/股,成交量8052股,换手率0.36%,振幅0.95%。Moleculin Biotech, Inc.股票所在的生物技术行业中,整体涨幅为0.37%。Moleculin Biotech, Inc.公司简介:Moleculin Biotech Inc是一家临床阶段的制药公司,专注于通过开发其候选药物来治疗高度耐药的癌症和病毒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403262134098b6578b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403262134098b6578b4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422753548","title":"Moleculin Biotech, Inc.盘中异动 快速上涨5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422753548","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422753548?lang=zh_cn&edition=full","pubTime":"2024-03-25 21:30","pubTimestamp":1711373437,"startTime":"0","endTime":"0","summary":"北京时间2024年03月25日21时30分,Moleculin Biotech, Inc.股票出现波动,股价大幅拉升5.18%。Moleculin Biotech, Inc.股票所在的生物技术行业中,整体跌幅为0.13%。其相关个股中,Landos Biopharma, Inc.、Altamira Therapeutics Ltd.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大,Altamira Therapeutics Ltd.、Salarius Pharmaceuticals, Inc.、Moleculin Biotech, Inc.较为活跃,换手率分别为585.50%、46.20%、30.60%,振幅较大的相关个股有Xtl生物制药、Cara Therapeutics, Inc.、Aim Immunotech Inc.,振幅分别为7.25%、7.03%、6.63%。Moleculin Biotech, Inc.公司简介:Moleculin Biotech Inc是一家临床阶段的制药公司,专注于通过开发其候选药物来治疗高度耐药的癌症和病毒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032521303887e7b767&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032521303887e7b767&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421879866","title":"Moleculin 生物技术公司公布截至 12 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2421879866","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2421879866?lang=zh_cn&edition=full","pubTime":"2024-03-23 06:21","pubTimestamp":1711146078,"startTime":"0","endTime":"0","summary":" * Moleculin Biotech Inc 报告了截至12月底的季度调整后每股亏损5.02美元,低于去年同期的每股收益3.45美元。三位分析师对该季度的平均预期是每股亏损 3.05 美元。华尔街预期为每股亏损 3.15 美元至 2.85 美元。* Moleculin Biotech Inc 公布的季度每股收益为亏损 5.02 美元。* 该公司的季度亏损额为 1,027 万美元。* Moleculin Biotech Inc 本季度股价下跌了 48.5%。* 医药同行的平均一致建议也是 \"买入\"。华尔街对 Moleculin Biotech Inc 的 12 个月目标价中位数为 45.00 美元。本摘要由 LSEG 3 月 22 日 10:20 p.m. UTC 数据机器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2421450720","title":"Moleculin Biotech, Inc.盘中异动 大幅拉升6.99%报0.450美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2421450720","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421450720?lang=zh_cn&edition=full","pubTime":"2024-03-21 21:42","pubTimestamp":1711028525,"startTime":"0","endTime":"0","summary":"北京时间2024年03月21日21时42分,Moleculin Biotech, Inc.股票出现异动,股价快速上涨6.99%。截至发稿,该股报0.450美元/股,成交量9.5128万股,换手率0.28%,振幅8.11%。Moleculin Biotech, Inc.股票所在的生物技术行业中,整体涨幅为0.75%。Moleculin Biotech, Inc.公司简介:Moleculin Biotech Inc是一家临床阶段的制药公司,专注于通过开发其候选药物来治疗高度耐药的癌症和病毒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032121420587e7ab86&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032121420587e7ab86&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420280854","title":"Moleculin Biotech Inc 预计每股亏损 20 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2420280854","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2420280854?lang=zh_cn&edition=full","pubTime":"2024-03-19 04:22","pubTimestamp":1710793331,"startTime":"0","endTime":"0","summary":" * Moleculin Biotech Inc 预计在3月20日发布业绩报告时,季度营收将保持不变() 预计截至2023年12月31日的业绩将保持不变。* * LSEG 的分析师平均预计 Moleculin Biotech Inc 每股亏损 20 美分。* 华尔街对 Moleculin Biotech Inc 的 12 个月目标价中位数为 3.00 美元,高于上一次 0.49 美元的收盘价。3月18日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问,请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2419053908","title":"Moleculin Biotech, Inc.盘中异动 早盘急速下跌8.33%报0.491美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419053908","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419053908?lang=zh_cn&edition=full","pubTime":"2024-03-15 22:31","pubTimestamp":1710513084,"startTime":"0","endTime":"0","summary":"北京时间2024年03月15日22时31分,Moleculin Biotech, Inc.股票出现异动,股价大幅跳水8.33%。截至发稿,该股报0.491美元/股,成交量1.859万股,换手率0.06%,振幅14.75%。Moleculin Biotech, Inc.股票所在的生物技术行业中,整体跌幅为0.44%。Moleculin Biotech, Inc.公司简介:Moleculin Biotech Inc是一家临床阶段的制药公司,专注于通过开发其候选药物来治疗高度耐药的癌症和病毒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240315223125861deb1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240315223125861deb1a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418251553","title":"Moleculin Biotech, Inc.盘中异动 早盘股价大跌6.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2418251553","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2418251553?lang=zh_cn&edition=full","pubTime":"2024-03-12 22:28","pubTimestamp":1710253687,"startTime":"0","endTime":"0","summary":"北京时间2024年03月12日22时28分,Moleculin Biotech, Inc.股票出现波动,股价快速下跌6.65%。Moleculin Biotech, Inc.股票所在的生物技术行业中,整体涨幅为0.61%。其相关个股中,Artelo Biosciences Inc C/Wts 20/06/2024 、Regulus Therapeutics Inc.、Tracon Pharmaceuticals, Inc.涨幅较大,Regulus Therapeutics Inc.、Tc Biopharm Plc、Scisparc Ltd.较为活跃,换手率分别为387.71%、240.11%、150.97%,振幅较大的相关个股有Regulus Therapeutics Inc.、Artelo Biosciences Inc C/Wts 20/06/2024 、Aslan Pharmaceuticals Limited,振幅分别为80.43%、74.77%、40.48%。Moleculin Biotech, Inc.公司简介:Moleculin Biotech Inc是一家临床阶段的制药公司,专注于通过开发其候选药物来治疗高度耐药的癌症和病毒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031222280887e78373&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031222280887e78373&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418439060","title":"Moleculin Biotech, Inc.盘中异动 临近收盘股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2418439060","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2418439060?lang=zh_cn&edition=full","pubTime":"2024-03-12 03:48","pubTimestamp":1710186485,"startTime":"0","endTime":"0","summary":"北京时间2024年03月12日03时48分,Moleculin Biotech, Inc.股票出现波动,股价快速跳水5.01%。Moleculin Biotech, Inc.股票所在的生物技术行业中,整体跌幅为0.32%。其相关个股中,Aslan Pharmaceuticals Limited、Tc Biopharm Plc C/Wts 10/02/2028 、Celularity Inc C/Wts 16/07/2026 涨幅较大,Tc Biopharm Plc、180 Life Sciences Corp.、Transcode Therapeutics, Inc.较为活跃,换手率分别为5691.53%、197.26%、120.38%,振幅较大的相关个股有Aslan Pharmaceuticals Limited、Tc Biopharm Plc、Tc Biopharm Plc C/Wts 10/02/2028 ,振幅分别为203.84%、152.82%、145.83%。Moleculin Biotech, Inc.公司简介:Moleculin Biotech Inc是一家临床阶段的制药公司,专注于通过开发其候选药物来治疗高度耐药的癌症和病毒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403120348067a4ba0fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403120348067a4ba0fb&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.moleculin.com","stockEarnings":[{"period":"1week","weight":0.0164},{"period":"1month","weight":-0.1714},{"period":"3month","weight":-0.4051},{"period":"6month","weight":-0.3958},{"period":"1year","weight":-0.6038},{"period":"ytd","weight":-0.6622}],"compareEarnings":[{"period":"1week","weight":0.0097},{"period":"1month","weight":-0.0276},{"period":"3month","weight":0.0356},{"period":"6month","weight":0.2307},{"period":"1year","weight":0.2446},{"period":"ytd","weight":0.0633}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Moleculin Biotech, Inc.是一家于2015年7月在特拉华州成立的临床药物研制公司,着眼于开发抗癌药物的研发,主要与德克萨斯州大学的M.D. Anderson癌症中心合作。他们的主要研制药品是脂质的安那霉素,用于治疗复发性或急性白血病。除此之外还有两种正在开发的其他药物,一是WP1066药物,主要控制参与癌症的关键转录调控因子;二是WP1122药物,主要通过分子靶来影响癌症细胞的代谢过程。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.042816},{"month":2,"riseRate":0.25,"avgChangeRate":-0.069703},{"month":3,"riseRate":0.25,"avgChangeRate":-0.110793},{"month":4,"riseRate":0.375,"avgChangeRate":0.063956},{"month":5,"riseRate":0.142857,"avgChangeRate":-0.063177},{"month":6,"riseRate":0.285714,"avgChangeRate":0.179766},{"month":7,"riseRate":0.625,"avgChangeRate":0.096418},{"month":8,"riseRate":0.25,"avgChangeRate":-0.088841},{"month":9,"riseRate":0,"avgChangeRate":-0.104695},{"month":10,"riseRate":0.125,"avgChangeRate":-0.150211},{"month":11,"riseRate":0.5,"avgChangeRate":0.055295},{"month":12,"riseRate":0.375,"avgChangeRate":-0.024821}],"exchange":"NASDAQ","name":"Moleculin Biotech, Inc.","nameEN":"Moleculin Biotech"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Moleculin Biotech, Inc.(MBRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Moleculin Biotech, Inc.(MBRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Moleculin Biotech, Inc.,MBRX,Moleculin Biotech, Inc.股票,Moleculin Biotech, Inc.股票老虎,Moleculin Biotech, Inc.股票老虎国际,Moleculin Biotech, Inc.行情,Moleculin Biotech, Inc.股票行情,Moleculin Biotech, Inc.股价,Moleculin Biotech, Inc.股市,Moleculin Biotech, Inc.股票价格,Moleculin Biotech, Inc.股票交易,Moleculin Biotech, Inc.股票购买,Moleculin Biotech, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Moleculin Biotech, Inc.(MBRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Moleculin Biotech, Inc.(MBRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}